Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

FHS
July 14, 2023
9:36 am

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

Biden administration should push for addiction medication in recovery houses, groups say

The Biden administration isn’t doing enough to ensure people living in recovery housing have access to gold-standard addiction medications like methadone and buprenorphine, according to

July 31, 2024

Vaccination amps up antibody response and cuts down COVID severity, UK study shows

UK study reveals COVID-19 vaccination effectively boosts anti-S antibody levels and reduces symptom severity post-infection, irrespective of the viral variant involved. High antibody levels are

September 11, 2023

Ascension, other hospitals played active roles to take medical billing company R1 RCM private

Private equity firms are leading the buyout of R1 RCM, a major provider of billing and administrative services for hospitals and physician groups. But R1’s

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.